BCM
AMPE

Brasada Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Brasada Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6
Closed -$1K – 284
2018
Q4 		$1K Hold
6
– – ﹤0.01% 284
2018
Q3 		$1K Hold
6
– – ﹤0.01% 371
2018
Q2 		$4K Buy
+6
New +$4.49K ﹤0.01% 271

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Brasada Capital Management's AMPE Position: Q1 2019 in Review

Brasada Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2019, closing a stake of 6 shares — an estimated $1K sold.

Brasada Capital Management first reported a position in AMPE in Q2 2018 and held it in 3 quarters. The position peaked at $4K in Q2 2018. 84 funds tracked by Wall St. Rank hold AMPE as of Q1 2019.

  • Brasada Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2019 after selling out during the quarter.
  • Brasada Capital Management sold 6 Ampio Pharmaceuticals Inc. shares in Q1 2019, an estimated $1K.
  • Brasada Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 3 quarters.
  • Brasada Capital Management's Ampio Pharmaceuticals Inc. position peaked at $4K in Q2 2018.
  • 84 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2019.

Based on Brasada Capital Management's 13F filing for Q1 2019, filed 6 May 2019.